Published by Iain Gilbert on 2nd January 2024
(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.
URL: http://www.digitallook.com/dl/news/story/33998906/...